LPL Financial’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-11,619
| Closed | -$2.13M | – | 4493 |
|
|
2021
Q2 | $2.13M | Sell |
11,619
-8,415
| -42% | -$1.44M | ﹤0.01% | 1924 |
|
|
2021
Q1 | $3.06M | Sell |
20,034
-50,890
| -72% | -$7.87M | ﹤0.01% | 1559 |
|
|
2020
Q4 | $11.1M | Buy |
70,924
+7,628
| +12% | +$980K | 0.01% | 705 |
|
|
2020
Q3 | $7.24M | Sell |
63,296
-494
| -0.8% | -$53.3K | 0.01% | 775 |
|
|
2020
Q2 | $7.16M | Buy |
63,790
+15,892
| +33% | +$1.69M | 0.01% | 708 |
|
|
2020
Q1 | $4.3M | Buy |
47,898
+1,669
| +4% | +$164K | 0.01% | 807 |
|
|
2019
Q4 | $5M | Buy |
46,229
+7,837
| +20% | +$838K | 0.01% | 837 |
|
|
2019
Q3 | $3.76M | Sell |
38,392
-757
| -2% | -$85.3K | 0.01% | 920 |
|
|
2019
Q2 | $5.13M | Buy |
39,149
+1,374
| +4% | +$177K | 0.01% | 782 |
|
|
2019
Q1 | $5.11M | Buy |
37,775
+7,759
| +26% | +$965K | 0.01% | 752 |
|
|
2018
Q4 | $2.92M | Buy |
30,016
+824
| +3% | +$97.4K | 0.01% | 909 |
|
|
2018
Q3 | $4.06M | Buy |
29,192
+1,026
| +4% | +$129K | 0.01% | 834 |
|
|
2018
Q2 | $3.5M | Buy |
28,166
+457
| +2% | +$53.4K | 0.01% | 871 |
|
|
2018
Q1 | $3.09M | Buy |
27,709
+5,260
| +23% | +$629K | 0.01% | 900 |
|
|
2017
Q4 | $2.69M | Sell |
22,449
-2,804
| -11% | -$341K | 0.01% | 896 |
|
|
2017
Q3 | $3.53M | Buy |
25,253
+9,927
| +65% | +$1.35M | 0.01% | 730 |
|
|
2017
Q2 | $1.86M | Sell |
15,326
-11,223
| -42% | -$1.31M | 0.01% | 986 |
|
|
2017
Q1 | $3.17M | Buy |
26,549
+3,316
| +14% | +$428K | 0.02% | 609 |
|
|
2016
Q4 | $2.85M | Sell |
23,233
-1,323
| -5% | -$162K | 0.02% | 630 |
|
|
2016
Q3 | $3.03M | Buy |
24,556
+10,540
| +75% | +$1.36M | 0.03% | 566 |
|
|
2016
Q2 | $1.7M | Buy |
14,016
+5,380
| +62% | +$763K | 0.01% | 849 |
|
|
2016
Q1 | $1.28M | Sell |
8,636
-1,242
| -13% | -$182K | ﹤0.01% | 1490 |
|
|
2015
Q4 | $1.83M | Sell |
9,878
-1,506
| -13% | -$263K | 0.01% | 1235 |
|
|
2015
Q3 | $1.86M | Buy |
11,384
+1,501
| +15% | +$274K | 0.01% | 871 |
|
|
2015
Q2 | $1.84M | Buy |
9,883
+246
| +3% | +$42.5K | 0.01% | 954 |
|
|
2015
Q1 | $1.63M | Sell |
9,637
-6,055
| -39% | -$1.1M | 0.01% | 1022 |
|
|
2014
Q4 | $2.9M | Buy |
15,692
+524
| +3% | +$97.1K | 0.02% | 711 |
|
|
2014
Q3 | $2.54M | Buy |
15,168
+3,407
| +29% | +$560K | 0.02% | 743 |
|
|
2014
Q2 | $1.84M | Buy |
11,761
+1,142
| +11% | +$180K | 0.01% | 933 |
|
|
2014
Q1 | $1.61M | Sell |
10,619
-2,514
| -19% | -$400K | 0.01% | 949 |
|
|
2013
Q4 | $1.75M | Buy |
13,133
+3,041
| +30% | +$365K | 0.01% | 907 |
|
|
2013
Q3 | $1.08M | Sell |
10,092
-438
| -4% | -$48.1K | 0.01% | 1144 |
|
|
2013
Q2 | $971K | Buy |
+10,530
| New | +$1.01M | 0.01% | 1141 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM